Proactive Investors - Run By Investors For Investors

Axim Biotechnologies receives patent for its purification and extraction methods of THC from cannabis

The cannabinoid research firm uses the method to produce pure THC for use in pharmaceuticals
Medical marijuana
The pure THC is used in its MedChew RX, a chewing gum for patients with multiple sclerosis

Axim Biotechnologies Inc (OTCQB:AXIM) has received a US patent for its method of purification and extraction of THC from medicinal cannabis.

The cannabinoid research and development firm’s process produces pure THC molecules that can be used as the active ingredient in pharmaceuticals.

READ: WeedMD to supply cannabidiol for new research looking at liver disease treatments

The biotech uses the method to extract THC for use in its MedChew RX program, a controlled-release chewing gum that can treat pain and spasticity in patients with multiple sclerosis.

“In our industry it is not only research and trials that enable companies to bring medications to market, but a consistent supply of pure molecules is necessary to achieve FDA compliance,” said CEO George E. Anastassov in a statement.

An estimated 2.3 million people are living with multiple sclerosis, according to the National MS Society.

Shares of the New York-based company fell slightly to US$3.20 in Tuesday afternoon trading.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full AXIM profile View Profile

AXIM Biotechnologies Timeline

Related Articles

Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
skin
Wed
Driving growth was Lojuxta, used to treat a rare and life-threatening disorder that causes abnormally high levels of bad cholesterol. Its sales grew to €13.6mln, up 14.2% year-on-year
Oncoprex
October 17 2018
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use